论文部分内容阅读
目的:观察倍他乐克治疗慢性充血性心力衰竭(CHF)的临床疗效。方法:选择病因不同的慢性充血性心力衰竭患者60例,在常规应用利尿剂、ACEI、洋地黄和(或)硝酸制剂治疗的基础上,加用倍他乐克(治疗组),同时按常规治疗60例CHF(对照组),比较两组的疗效。结果:应用倍他乐克后心力衰竭患者心功能分级显著改善,显效率和有效率提高(P<0.05),心率降低,LVEF显著升高(P<0.01)。结论:在常规治疗CHF的基础上加用倍他乐克可以明显改善心功能,增加LVEF,改善心室重塑,提高治疗CHF的疗效。
Objective: To observe the clinical efficacy of metoprolol in the treatment of chronic congestive heart failure (CHF). Methods: Sixty patients with congestive heart failure of different etiology were enrolled in this study. Betaloc (treatment group) was given on the basis of conventional diuretic, ACEI, digitalis and / or nitric acid preparations. At the same time, Treatment of 60 cases of CHF (control group), the efficacy of the two groups were compared. Results: After treatment with metoclopramide, heart function scores of patients with heart failure were significantly improved, markedly effective rate and effective rate increased (P <0.05), heart rate decreased, LVEF increased significantly (P <0.01). Conclusion: Betaloc can improve heart function, increase LVEF, improve ventricular remodeling and improve the curative effect of CHF on the basis of routine treatment of CHF.